IN-DATE
JADA-2002: Organon Jada Vacuum-Induced Postpartum Hemorrhage Control
Sign in to add this product to your favorites!
| Price: | $149.00 per kit |
|---|---|
| Quantity: | |
| In Stock: | 21 kits |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 5 hours 37 minutes and choose overnight shipping at checkout. |
Related Items
QUICK VIEW
| JADA-1001 $149.00 EACH Organon Jada Vacuum-Induced Hemorrhage Control Expired Out of Stock |
QUICK VIEW
| JADA-2001 $149.00 EACH Organon Jada Vacuum-Induced Postpartum Hemorrhage Control, Device Only Expired Units in stock: 5 | Order Qty |
QUICK VIEW
| G24237 - Size: 24.0F $99.00 per box of 1 Cook Bakri Postpartum Balloon w/Rapid Instillation: 24F / 54cm, 500ml Expired Units in stock: 101 box of 1 | Order Qty |
Additional Details
Organon Jada Vacuum-Induced Postpartum Hemorrhage Control
Item # JADA-2002
- Vacuum-Induced Hemorrhage Control System
- Luer-Lock Syringe 60ml
- Universal Vacuum Tubing 1/4" x 12'
AccessGUDID Info
- FDA Product Code: OQY
- FDA Product Code Name: Intrauterine tamponade balloon
- GMDN Term Code: 61558
- GMDN Term Name: Intrauterine haemostatic suction catheter
- GMDN Term Description: A sterile, flexible tube with a fenestrated loop at its distal end intended to be connected to a vacuum supply and inserted into the uterus to reduce postpartum bleeding through aspiration of blood/debris and induction of uterine contractions. It may have an additional balloon inflated in the upper vagina to seal the uterine cavity. This is a single-use device.
Manufacturer
Organon is a global healthcare company that focuses on women's health, biosimilars, and medicines for other unmet medical needs. It was spun off from Merck & Co. in 2021 and operates as an independent entity. Organon’s portfolio includes contraceptive products, fertility treatments, biosimilar medicines, and women's health therapies. The company is well known for offering products that address hormonal therapies, gynecological conditions, and family planning. Organon also has a growing focus on biosimilars in oncology and immunology. By focusing on improving health outcomes for women and addressing unmet medical needs, Organon strives to provide accessible, affordable healthcare solutions globally.
